The increase in focal adhesion formation is not dependent on the ability of LCN2 to bind iron but is dependent on the LCN2-mediated activation of the tyrosine kinase c-Src, suggesting that inhibiting c-Src function in invasive colorectal cancer could be a potential therapeutic mechanism in tumors with high levels of LCN2. This evidence concerns the gene LCN2 and colorectal cancer.